DUBLIN, Oct. 15, 2024 (Globe Newswire) — The “mRNA Therapeutics Market Report 2024” report has been added to ResearchAndMarkets.com’s offering.
The market size of mRNA therapeutics has been steadily growing in recent years. It is expected to grow at a compound annual growth rate (CAGR) of 3.8%, from $33.5 billion in 2023 to $34.76 billion in 2024. The market size of mRNA therapeutics is expected to grow steadily in the coming years. It is expected to grow to $40.69 billion by 2028 at a compound annual growth rate (CAGR) of 4%.
Growth during this historic period has been driven by increased financial support for the development of efficient drugs and vaccines, expanded federal programs focused on advances in RNA-based medicines, increased awareness of rare genetic diseases, and increased numbers of people infected. It was driven by several factors, including the increase in A clinical trial was conducted.
In the forecast period, there will be a rise in the prevalence of infectious diseases, an increase in the number of patients visiting hospitals and clinics, a wide application of mRNA therapeutics, an increasing demand for personalized precision medicine, a favorable regulatory environment, and an acceleration of regulations. Growth is expected to be driven by several factors, including: Approval route. Key trends expected during this period include advances in mRNA delivery technologies, rapid development and adaptation of mRNA vaccines, emergence of self-amplifying mRNA (saRNA) platforms, increased scalability and flexibility in mRNA manufacturing, and novel mRNA modifications. innovations included.
The mRNA therapeutics market is poised for growth due to the increasing prevalence of long-lasting infectious diseases. These diseases can last for long periods of time, can be transmitted between individuals, and include conditions such as tuberculosis, HIV/AIDS, and hepatitis. Factors contributing to this increase include global travel and inadequate health infrastructure, which facilitates the spread of the disease and impedes effective management. mRNA therapeutics are crucial in fighting such diseases by allowing the body to rapidly produce proteins that strengthen the immune response, thereby accelerating the development of vaccines and treatments.
Leading companies in the mRNA therapeutics market are focusing on pioneering solutions such as mRNA-based booster vaccines to strengthen immunity against evolving virus variants. These vaccines utilize messenger RNA (mRNA) technology to prolong and strengthen immunity against specific pathogens, especially after the first vaccination series.
Messenger RNA (mRNA) therapy uses mRNA molecules to stimulate the production of therapeutic proteins in cells. It aims to prevent, treat, or cure disease by promoting the production of specific proteins required for therapeutic efficacy.
The main products of mRNA therapeutics include vaccines and medicines. mRNA vaccines instruct cells via mRNA to produce proteins that stimulate an immune response against the target disease. These vaccines have applications in a variety of fields, including infectious diseases, oncology, rare genetic diseases, and respiratory diseases. End users include hospitals, clinics, research institutions, and other healthcare providers.
North America was the largest region for the mRNA therapeutics market in 2023. Asia Pacific is expected to be the fastest growing region over the forecast period. The regions covered in the mRNA therapeutics market report are Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Countries covered in the mRNA therapeutics market report are Australia, Brazil, China, France, and Germany. , India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Competitive environment and company overview of the mRNA therapeutic drug market
Pfizer Inc. OverviewProducts and ServicesStrategyFinancial PerformanceNovartis AGSanofi AGAstraZeneca plcGlaxoSmithKline plc
Other leading and innovative companies in the mRNA therapeutics market
Hoffmann-La Roche AGMModerna Therapeutics IncBioNTech SEVertex Pharmaceuticals IncorporatedCatalent IncAlnylam Pharmaceuticals IncSarepta Therapeutics IncArcturus Therapeutics Holdings IncCureVac N.VEthris GMBHeTheRNA immunotherapies NVin-Cell-Art SaSNutcracker Therapeutics IncSCM LifeScience Co LtdSuzhou Abogen Biosciences Co Ltd
Key attributes:
Report attribute details No. Number of pages 175 Forecast period 2024 – 2028 Estimated market value in 2024 (USD) 34.76 billion USD Predicted market value by 2028 (USD) 40.69 billion USD Average annual growth rate 4.0% Target region world
Main topics covered:
1. Summary
2. Characteristics of the mRNA therapeutic drug market
3. Trends and strategies in the mRNA therapeutic drug market
4. mRNA Therapeutics Market – Macroeconomic Scenario
4.1. Impact of high inflation on the market
4.2. Impact of the Ukraine-Russia war on the market
4.3. Impact of the new coronavirus infection on the market
5. Global mRNA therapeutic drug market size and growth
5.1.Global mRNA Therapeutics Market Driving and Constraining Factors
5.1.1. Market drivers
5.1.2. Market constraints
5.2. Global mRNA Therapeutics Market Historical Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global mRNA Therapeutics Market Size and Growth Forecast, 2023-2028, 2033F, Value ($ Billion)
6. Segmentation of the mRNA therapeutics market
6.1. Global mRNA Therapeutics Market, Segmentation by Product, Historical and Forecast, 2018-2023, 2023-2028, 2033, $ Billion
6.2. Global mRNA Therapeutics Market, Segmentation by Application, Historical and Forecast, 2018-2023, 2023-2028, 2033, $ Billion
Infectious diseases Oncology Rare genetic diseases Respiratory diseases Other uses
6.3. Global mRNA Therapeutics Market, Segmentation by End Use, Historical and Forecast, 2018-2023, 2023-2028, 2033, $ Billion
Hospitals and clinics research institutes and other end uses
7. Regional and Country Analysis of mRNA Therapeutics Market
7.1. Global mRNA Therapeutics Market, By Regions, Historical and Forecast, 2018-2023, 2023-2028, 2033, $ Billion
7.2. Global mRNA Therapeutics Market, By Country, Historical and Forecast, 2018-2023, 2023-2028, 2033, $ Billion
For more information on this report, please visit https://www.researchandmarkets.com/r/3fmsln.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
